NCT04583982 - ImmuneSense™ COVID-19 Study | Biotech Hunter

Enrollment

180

Participants

Timeline

Start Date

October 9, 2020

Primary Completion Date

December 4, 2020

Study Completion Date

December 4, 2020

Conditions

Coronavirus Disease (COVID-19)SARS-CoV-2 Infection

Interventions

OTHER

T-Detect™ SARS-CoV-2 Assay

T-Detect™ SARS-CoV-2 Assay is an investigational device that is indicated to assess T-cell immune response to SARS-CoV-2 via the testing of blood samples from patients with signs and symptoms of suspected COVID-19. These results will not be shared with the participant.

Trial Locations (1)

07094

Adaptive Biotechnologies Clinical Investigational Site, Secaucus